Inventor · disambiguated record
James Aggen
Also filed as: AGGEN JAMES · AGGEN JAMES B · AGGEN JAMES BRADLEY
55 granted patents·31 pending applications·1,064 citations·filing 2000–2025
99Inventor score
Files withTHERAVANCE INC16REVOLUTION MEDICINES INC15ACHAOGEN INC14CHEMOCENTRYX INC7KODIAK SCIENCES INC6
Top patents by PatentIndex Score
86 records- 0199US6693202B1Muscarinic receptor antagonistsTHERAVANCE INC·Filed 2000·Granted Feb 17, 2004·253 cites·11 claims
- 0299US6653323B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2002·Granted Nov 25, 2003·100 cites·23 claims
- 0398US6670376B1Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2002·Granted Dec 30, 2003·129 cites·40 claims
- 0497US7341993B2Cross-linked glycopeptide—cephalosporin antibioticsTHERAVANCE INC·Filed 2005·Granted Mar 11, 2008·22 cites·2 claims
- 0597US6974797B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2002·Granted Dec 13, 2005·45 cites·25 claims
- 0696US11739074B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Aug 29, 2023·9 cites·2 claims
- 0796US11590235B2Factor VIII zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2020·Granted Feb 28, 2023·5 cites·15 claims
- 0896US7332471B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2006·Granted Feb 19, 2008·21 cites·23 claims
- 0996US7279458B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2006·Granted Oct 9, 2007·50 cites·12 claims
- 1095US11685749B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 27, 2023·5 cites·8 claims
- 1195US11364300B2C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 21, 2022·6 cites·11 claims
- 1295US10980889B1C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Apr 20, 2021·8 cites·6 claims
- 1395US7067481B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Jun 27, 2006·41 cites·35 claims
- 1494US12187746B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jan 7, 2025·5 cites·9 claims
- 1593US12048749B2C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Jul 30, 2024·3 cites·10 claims
- 1693US9840553B2Dual PDGF/VEGF antagonistsKODIAK SCIENCES INC·Filed 2015·Granted Dec 12, 2017·18 cites·34 claims
- 1793US8383596B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2009·Granted Feb 26, 2013·17 cites·44 claims
- 1893US6949568B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2003·Granted Sep 27, 2005·23 cites·11 claims
- 1992US11155610B2Dual PDGF/VEGF antagonistsKODIAK SCIENCES INC·Filed 2017·Granted Oct 26, 2021·7 cites·22 claims
- 2092US10702608B2Factor VIII zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2014·Granted Jul 7, 2020·10 cites·20 claims
- 2192US7067482B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Jun 27, 2006·43 cites·28 claims
- 2291US9403758B2Antibacterial agentsACHAOGEN INC·Filed 2014·Granted Aug 2, 2016·8 cites·18 claims
- 2390US9688711B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2016·Granted Jun 27, 2017·7 cites·16 claims
- 2490US8318685B2Antibacterial aminoglycoside analogsGOLDBLUM ADAM AARON·Filed 2011·Granted Nov 27, 2012·19 cites·27 claims
- 2589US7435831B2Bicyclic and bridged nitrogen heterocyclesCHEMOCENTRYX INC·Filed 2005·Granted Oct 14, 2008·8 cites·14 claims
- 2688US7449576B1Substituted piperazinesCHEMOCENTRYX INC·Filed 2006·Granted Nov 11, 2008·15 cites·7 claims
- 2787US8822424B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2013·Granted Sep 2, 2014·7 cites·32 claims
- 2887US7157464B2Substituted piperazinesCHEMOCENTRYX INC·Filed 2003·Granted Jan 2, 2007·33 cites·18 claims
- 2986US8367625B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2011·Granted Feb 5, 2013·10 cites·27 claims
- 3085US8372813B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2011·Granted Feb 12, 2013·9 cites·27 claims
- 3185US7589199B2Substituted piperazinesCHEMOCENTRYX INC·Filed 2004·Granted Sep 15, 2009·18 cites·7 claims
- 3285US7582765B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2007·Granted Sep 1, 2009·2 cites·16 claims
- 3385US7435830B2Bicyclic and bridged nitrogen heterocyclesCHEMOCENTRYX INC·Filed 2005·Granted Oct 14, 2008·10 cites·29 claims
- 3485US7125892B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2003·Granted Oct 24, 2006·16 cites·4 claims
- 3584US8492354B2Antibacterial aminoglycoside analogsDOZZO PAOLA·Filed 2011·Granted Jul 23, 2013·7 cites·18 claims
- 3684US8481502B2Antibacterial aminoglycoside analogsAGGEN JAMES BRADLEY·Filed 2012·Granted Jul 9, 2013·10 cites·29 claims
- 3783US9266919B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2014·Granted Feb 23, 2016·4 cites·32 claims
- 3883US8653042B2Antibacterial aminoglycoside analogsDOZZO PAOLA·Filed 2011·Granted Feb 18, 2014·8 cites·9 claims
- 3983US8524675B2Antibacterial aminoglycoside analogsDOZZO PAOLA·Filed 2011·Granted Sep 3, 2013·8 cites·20 claims
- 4083US8524689B2Antibacterial aminoglycoside analogsGOLDBLUM ADAM AARON·Filed 2011·Granted Sep 3, 2013·8 cites·20 claims
- 4183US7871997B2Cephalosporin compoundsTHERAVANCE INC·Filed 2007·Granted Jan 18, 2011·1 cites·11 claims
- 4281US8399419B2Antibacterial aminoglycoside analogsAGGEN JAMES BRADLEY·Filed 2011·Granted Mar 19, 2013·9 cites·29 claims
- 4381US7842693B2Substituted piperazinesCHEMOCENTRYX INC·Filed 2003·Granted Nov 30, 2010·11 cites·23 claims
- 4480US12214044B2Factor VIII zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 4580US8324216B2Substituted piperazinesPENNELL ANDREW M K·Filed 2009·Granted Dec 4, 2012·4 cites·8 claims
- 4679US8658606B2Antibacterial aminoglycoside analogsGOLDBLUM ADAM AARON·Filed 2011·Granted Feb 25, 2014·5 cites·9 claims
- 4778US8653041B2Antibacterial aminoglycoside analogsACHAOGEN INC·Filed 2012·Granted Feb 18, 2014·3 cites·20 claims
- 4875USRE47741EAntibacterial aminoglycoside analogsACHAOGEN INC·Filed 2018·Granted Nov 26, 2019·1 cites·22 claims
- 4975US2025051306A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 5075US2023374035A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James Aggen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →